Neera Clase
CIK: 0002162845
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TARS
Tarsus Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Clase Neera
Clase Neera (SEC CIK 0002162845) files insider reports with the SEC as Chief Commercial Officer of Tarsus Pharmaceuticals, Inc. (TARS).
Signal8 holds 2 ownership filings by Clase Neera (1 Form 3, 1 Form 4), filed on Nov 5, 2026. Those filings report 2 transactions, the latest on Nov 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Clase Neera's filings is in IRVINE, CA.
Recent filings by Clase Neera
- Nov 3, 2026: Grants or awards of TARS derivative securities (2 lines, Form 4, code A).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- YARNO WENDY L, Director
- LINK WILLIAM J PHD, Director
- Azamian Bobak R., President/CEO and Board Chair
- Lin Elizabeth Yeu, Chief Medical Officer
- Neervannan Seshadri, Chief Operating Officer